WUXAY logo

WUXAY WuXi AppTec Co., Ltd.

Other OTC · Medical - Diagnostics & Research · Healthcare

$25.55
-0.01 (-0.04%)

WuXi AppTec Co., Ltd. functions as an investment holding entity, globally delivering a wide array of research, development, and manufacturing services. Operating across the People's Republic of China, other parts of Asia, the United States, and Europe, the company plays a crucial role in the discovery, advancement, and production of small molecule pharmaceuticals, as well as cell and gene therapie…

Market Cap: $74.06Bwww.wuxiapptec.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

85
85
Aug 11Aug 11

Quote

Day Range
$25.55 – $26.04
52-Week Range
$12.45 – $26.04
Volume
$1.6K
Market Cap
$74.06B
50-Day Avg
$19.63
200-Day Avg
$15.96
Prev Close
$25.56
Open
$26.04

Valuation & Ratios

P/E Ratio
13.06
EPS
$6.75
P/B Ratio
3.14
P/S Ratio
5.50
Debt/Equity
0.10
Current Ratio
3.21
Dividend Yield
+2.0%
Gross Margin
+47.6%

Returns & Efficiency

Return on Equity
+24.0%
Return on Assets
+18.6%
FCF Yield
+4.7%
EV/EBITDA
8.06

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$45.46B$19.15B$6.75
2024$39.24B$9.45B$3.28
2023$40.34B$9.61B$3.24
2022$39.35B$8.81B$3.01
2021$22.90B$5.10B$1.75

Social Signal Score

35
5d
35
1 mentions
30d
35
1 mentions
60d
35
1 mentions
90d
35
1 mentions
news: 1

Earnings

Mon, Aug 17(tomorrow)

Consensus estimate $0.23 per share

4of 6 quarters beat consensus

Typical surprise +20.3% (median, so one quarter with a near-zero estimate can't distort it)

  • Mon, Apr 27$0.23 vs $0.18beat
  • Mon, Mar 23$0.37 vs $0.38miss
  • Fri, Oct 31$0.17 vs $0.15beat
  • Mon, Jul 28$0.24 vs $0.19beat
  • Mon, Apr 28$0.18 vs $0.11beat
  • Mon, Mar 17$0.14 vs $0.16miss

Estimates and results for WUXAY via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

Project earnings forward and see what return today's price implies.

Seeded from WUXAY's reported EPS growth of 40.1% a year over 4 years. Historical EPS growth of 40% reflects a recovery from a low base and won't persist. Capped at 30% as a starting point.

EPS in 5 years
$25.07
Implied price
$325.94
Return from $25.55
66.4% a year

To earn 15.0% a year on these assumptions you'd need to buy at $162.05 — today's price is already 84.2% below that.

How sensitive is that answer?

Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.

growth \ P/E911131517
20.0%42.7%48.6%53.6%58.1%62.1%
25.0%48.7%54.7%60.0%64.6%68.8%
30.0%54.6%60.9%66.4%71.2%75.6%
35.0%60.5%67.1%72.8%77.8%82.3%
40.0%66.5%73.3%79.2%84.4%89.1%

This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.

Mentions (1)

  • Newszacks.com·4d ago·Negative

    Here's Why Momentum in Wuxi Apptec Co Ltd. - Sponsored ADR (WUXAY) Should Keep going Wuxi Apptec Co Ltd. - Sponsored ADR (WUXAY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks.

    View source ↗